128 related articles for article (PubMed ID: 26407478)
1. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
Andersen CL; Eskelund CW; Siersma VD; Felding P; Lind B; Palmblad J; Bjerrum OW; Friis S; Hasselbalch HC; de Fine Olivarius N
Gynecol Oncol; 2015 Nov; 139(2):312-8. PubMed ID: 26407478
[No Abstract] [Full Text] [Related]
2. Relationship between epidermal growth factor receptor and other prognostic factors in gynecological cancers.
Melpignano M; Vadora E; Debiasi D; Merisio C; Piombo S; Brusati M; Catozzi L; Giovannini G; Piffanelli A; Merialdi A
Acta Biomed Ateneo Parmense; 1993; 64(5-6):227-34. PubMed ID: 7992560
[TBL] [Abstract][Full Text] [Related]
3. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.
Scholz HS; Petru E; Gücer F; Haas J; Tamussino K; Winter R
Anticancer Res; 2000; 20(5C):3983-5. PubMed ID: 11268488
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
5. [Blood groups of the ABO system and survival rate in gynecologic tumors].
Marinaccio M; Traversa A; Carioggia E; Valentino L; Coviello M; Salamanna S; Dragone DC; Marinaccio L
Minerva Ginecol; 1995 Mar; 47(3):69-76. PubMed ID: 7630512
[TBL] [Abstract][Full Text] [Related]
6. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies.
Melichar B; Solichová D; Freedman RS
Int J Gynecol Cancer; 2006; 16(1):240-52. PubMed ID: 16445639
[TBL] [Abstract][Full Text] [Related]
7. [International statistics on gynecological cancer are compiled in Stockholm].
Pettersson F
Lakartidningen; 1992 Dec; 89(50):4410-2. PubMed ID: 1469984
[No Abstract] [Full Text] [Related]
8. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
9. Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003.
Jensen KE; Hannibal CG; Nielsen A; Jensen A; Nøhr B; Munk C; Kjaer SK
Eur J Cancer; 2008 Sep; 44(14):2003-17. PubMed ID: 18662869
[TBL] [Abstract][Full Text] [Related]
10. Synchronous primary malignancies of the female genital tract.
Ayhan A; Yalçin OT; Tuncer ZS; Gürgan T; Küçükali T
Eur J Obstet Gynecol Reprod Biol; 1992 Jun; 45(1):63-6. PubMed ID: 1618363
[TBL] [Abstract][Full Text] [Related]
11. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
[TBL] [Abstract][Full Text] [Related]
12. Survival of Danish cancer patients 1943-1987. Female genital organs.
Kjaer SK; Storm HH
APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
[TBL] [Abstract][Full Text] [Related]
13. Reasons for diagnostic delay in gynecological malignancies.
Vandborg MP; Christensen RD; Kragstrup J; Edwards K; Vedsted P; Hansen DG; Mogensen O
Int J Gynecol Cancer; 2011 Aug; 21(6):967-74. PubMed ID: 21792008
[TBL] [Abstract][Full Text] [Related]
14. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Tan W; Stehman FB; Carter RL
Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 serum levels in patients with gynecological tumors.
Scambia G; Testa U; Panici PB; Martucci R; Foti E; Petrini M; Amoroso M; Masciullo V; Peschle C; Mancuso S
Int J Cancer; 1994 May; 57(3):318-23. PubMed ID: 8168990
[TBL] [Abstract][Full Text] [Related]
16. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
[TBL] [Abstract][Full Text] [Related]
17. [Gynecological cancers and pregnancy: the point of view of the oncology gynecologist].
Morice P; Camatte S; Pautier P; Castaigne V; Germann N; Pomel C; Haie-Meder C; Lhommé C; Duvillard P; Dargent D; Castaigne D
Bull Cancer; 2002 Sep; 89(9):765-71. PubMed ID: 12368128
[TBL] [Abstract][Full Text] [Related]
18. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis.
Kim YZ; Kwon JH; Lim S
J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.
Ventriglia J; Paciolla I; Pisano C; Cecere SC; Di Napoli M; Tambaro R; Califano D; Losito S; Scognamiglio G; Setola SV; Arenare L; Pignata S; Della Pepa C
Cancer Treat Rev; 2017 Sep; 59():109-116. PubMed ID: 28800469
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis in gynecological cancers.
Sharma D; Singh G
J Cancer Res Ther; 2017; 13(2):193-197. PubMed ID: 28643732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
